Structural and solution chemistry, antiproliferative effects, and serum albumin binding of three pseudohalide derivatives of auranofin

被引:12
作者
Cirri, Damino [1 ]
Fabbrini, Maria Giulia [1 ]
Massai, Lara [1 ]
Pillozzi, Serena [2 ]
Guerri, Annalisa [1 ]
Menconi, Alessio [2 ]
Messori, Luigi [1 ]
Marzo, Tiziano [3 ]
Pratesi, Alessandro [4 ]
机构
[1] Univ Florence, Dept Chem, Via Lastruccia 3, I-50019 Sesto Fiorentino, Italy
[2] Univ Florence, Dept Expt & Clin Med, Viale GB Morgagni 50, I-50134 Florence, Italy
[3] Univ Pisa, Dept Pharm, Via Bonanno Pisano 6, I-56126 Pisa, Italy
[4] Univ Pisa, Dept Chem & Ind Chem, Via G Moruzzi 13, I-56124 Pisa, Italy
关键词
Metal based drugs; NMR; Cancer; Protein metalation; BSA; COMPLEXES; ET3PAUCL; AGENTS;
D O I
10.1007/s10534-019-00224-1
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Three pseudohalide analogues of the established gold drug auranofin (AF hereafter), of general formula Au(PEt3)X, i.e. Au(PEt3)CN, Au(PEt3)SCN and Au(PEt3)N-3 (respectively denoted as AFCN, AFSCN and AFN(3)), were prepared and characterized. The crystal structure was solved for Au(PEt3)SCN highlighting the classical linear geometry of the 2-coordinate gold(I) center. The solution behaviour of the compounds was then comparatively analysed through (PNMR)-P-31 providing evidence for an acceptable stability under physiological-like conditions. Afterward, the reaction of these gold compounds with bovine serum albumin (BSA) and consequent adduct formation was investigated by (PNMR)-P-31. For all the studied gold compounds, the [Au(PEt3)](+) moiety was identified as the reactive species in metal/protein adducts formation. The cytotoxic effects of the complexes were subsequently measured in comparison to AF against a representative colorectal cancer cell line and found to be still relevant and roughly similar in the three cases though far weaker than those of AF. These results show that the nature of the anionic ligand can modulate importantly the pharmacological action of the gold-triethylphosphine moiety, affecting the cytotoxic potency. These aspects may be further explored to improve the pharmacological profiles of this family of metal complexes.
引用
收藏
页码:939 / 948
页数:10
相关论文
共 32 条
[1]   The Cambridge Structural Database: a quarter of a million crystal structures and rising [J].
Allen, FH .
ACTA CRYSTALLOGRAPHICA SECTION B-STRUCTURAL SCIENCE, 2002, 58 (3 PART 1) :380-388
[2]   SIR97:: a new tool for crystal structure determination and refinement [J].
Altomare, A ;
Burla, MC ;
Camalli, M ;
Cascarano, GL ;
Giacovazzo, C ;
Guagliardi, A ;
Moliterni, AGG ;
Polidori, G ;
Spagna, R .
JOURNAL OF APPLIED CRYSTALLOGRAPHY, 1999, 32 :115-119
[3]  
[Anonymous], 1995, J. Appl. Crystallogr, DOI [DOI 10.1107/S0021889895007138, 10.1107/S0021889895007138]
[4]  
[Anonymous], 2015, CRYSALISPRO 1 171 38
[6]   CLINICAL PHARMACOKINETICS OF ORAL AND INJECTABLE GOLD COMPOUNDS [J].
BLOCKA, KLN ;
PAULUS, HE ;
FURST, DE .
CLINICAL PHARMACOKINETICS, 1986, 11 (02) :133-143
[7]   PtI2(DACH), the iodido analogue of oxaliplatin as a candidate for colorectal cancer treatment: chemical and biological features [J].
Cirri, D. ;
Pillozzi, S. ;
Gabbiani, C. ;
Tricomi, J. ;
Bartoli, G. ;
Stefanini, M. ;
Michelucci, E. ;
Arcangeli, A. ;
Messori, L. ;
Marzo, T. .
DALTON TRANSACTIONS, 2017, 46 (10) :3311-3317
[8]  
COFFER MT, 1986, INORG CHEM, V25, P333
[9]   THIOL COMPETITION FOR ET3PAUS-ALBUMIN - A NONENZYMATIC MECHANISM FOR ET3PO FORMATION [J].
COFFER, MT ;
SHAW, CF ;
HORMANN, AL ;
MIRABELLI, CK ;
CROOKE, ST .
JOURNAL OF INORGANIC BIOCHEMISTRY, 1987, 30 (03) :177-187
[10]   SYNTHESIS AND SPECTROSCOPIC CHARACTERIZATION OF (TRIETHYLPHOSPHINE)GOLD(I) COMPLEXES AUX(PET3) (X=CL, BR, CN, SCN), [AUL(PET3)+] (L=SME2, SC(NH2)2, H2O), AND (MU-S)[AU(PET3)]2 [J].
ELETRI, MM ;
SCOVELL, WM .
INORGANIC CHEMISTRY, 1990, 29 (03) :480-484